Patents by Inventor Erin Filbert

Erin Filbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-L1 antibodies and methods of use
    Patent number: 11078283
    Abstract: Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: August 3, 2021
    Assignee: Apexigen, Inc.
    Inventors: Pia Björck, Christine Tan, Erin Filbert, Xiaodong Yang
  • ANTI-PD-L1 ANTIBODIES AND METHODS OF USE
    Publication number: 20190218296
    Abstract: Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
    Type: Application
    Filed: January 17, 2019
    Publication date: July 18, 2019
    Inventors: Pia Björck, Christine Tan, Erin Filbert, Xiaodong Yang